Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Oncogene
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
22 July 1999, Volume 18, Number 29, Pages 4237-4246
Table of contents    Previous  Abstract  Next   Full text  PDF
Article
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells
Alan B Tuck1,2,4, Denise M Arsenault3,4, Frances P O'Malley1, Charulata Hota4, Michael C Ling4, Sylvia M Wilson4 and Ann F Chambers2,4

1Department of Pathology, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada

2Department of Oncology, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada

3Department of Surgery, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada

4London Regional Cancer Centre, London, Ontario, Canada

Correspondence to: Alan B Tuck, Department of Pathology, London Health Sciences Centre, Victoria Campus, 375 South Street, London, Ontario N6A 4G5, Canada

Abstract

Osteopontin (OPN) has been associated with enhanced malignancy in breast cancer, but its functional role in this disease is poorly understood. To study the effect of OPN on cellular invasiveness, basal OPN expression was first assessed in members of a progression series of human mammary epithelial cell lines (21PT: immortalized, non-tumorigenic; 21NT: weakly tumorigenic; 21MT-1: tumorigenic, weakly metastatic; MDA-MB-435 cells: tumorigenic, highly metastatic). The two lines which expressed lowest basal levels of OPN (21PT, 21NT) were then examined for up-regulation of invasive behavior in response to exogenous or transfected (endogenous) OPN. Both 21PT and 21NT showed increased invasiveness through Matrigel when human recombinant (hr)OPN was added to the lower chamber of transwells. Both also showed a cell migration response to hrOPN. Populations of 21PT and 21NT cells stably transfected with an OPN-expression vector showed higher levels of cell invasiness than control vector transfectants. Examination of transfectants for mRNA of a number of secreted proteases showed that only urokinase-type plasminogen activator (uPA) expression was closely associated with OPN expression and cellular invasiveness. Treatment of the parental 21PT and 21NT cells with exogenous hrOPN resulted in increased uPA mRNA expression and increased urokinase activity of the conditioned media. Both increased cell migration and induction of uPA expression are thus potential mechanisms of increased invasiness of breast epithelial cells in response to OPN.

Keywords

osteopontin (OPN); invasion; plasminogen activator; urokinase; mammary epithelial cells; breast cancer

Received 20 May 1998; revised 4 February 1999; accepted 5 March 1999
22 July 1999, Volume 18, Number 29, Pages 4237-4246
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 1999 Nature Publishing Group